Contents

Current Pharmaceutical Design, Volume 13 - Number 3

Editorial [Hot Topic: Recent Advances and Future Prospect in Protease Targeting (Executive Editor: B. Turk)]

, 13(3): 251 - 252

Boris Turk


DOI: 10.2174/138161207779313597




Activity Based Probes for Proteases: Applications to Biomarker Discovery,Molecular Imaging and Drug Screening

, 13(3): 253 - 261

Marko Fonovic and Matthew Bogyo


DOI: 10.2174/138161207779313623




Proteomic Validation of Protease Drug Targets: Pharmacoproteomics of Matrix Metalloproteinase Inhibitor Drugs Using Isotope-Coded Affinity Tag Labelling and Tandem Mass Spectrometry

, 13(3): 263 - 270

G. S. Butler and C. M. Overall


DOI: 10.2174/138161207779313524




Aspartic Proteases in Drug Discovery

, 13(3): 271 - 285

Jorg Eder, Ulrich Hommel, Frederic Cumin, Bruno Martoglio and Bernd Gerhartz


DOI: 10.2174/138161207779313560




Recent Advances in Serine Protease Inhibitors as Anticoagulant Agents

, 13(3): 287 - 312

Andrej Prezelj, Petra Stefanic Anderluh, Luka Peternel and Uros Urleb


DOI: 10.2174/138161207779313605




Mast Cell Tryptase β as a Target in Allergic Inflammation: An Evolving Story

, 13(3): 313 - 332

C. P. Sommerhoff and N. Schaschke


DOI: 10.2174/138161207779313579




Matrix Metalloproteinases as Valid Clinical Target

, 13(3): 333 - 346

Barbara Fingleton


DOI: 10.2174/138161207779313551




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science